Our Leadership
Kevin Kobielski
Kevin’s experience, vision, and fundamental understanding of how the healthcare system really works helps ensure our clients get what they earn and bargain for. Kevin and his team focus on leveraging AlignRx’s expertise and empowering our clients with knowledge and strategies to select the right pharmacy and medical benefit solutions.
With unique experience as a senior executive in healthcare, Kevin knows how deals work from every angle. That vision gives his practice a fresh approach to solving the problems that hinder profitability and flexibility for TPAs, brokers, and health plans.
Before joining AlignRx, Kevin served as General Manager, Pharmacy Benefits Management (PBM) at HealthNow New York. He managed a team of clinical resources, operations personnel, and account managers responsible for over $600 million in medical and pharmacy spend, as well as 250 self-funded Rx clients covering 160,000 pharmacy lives. Throughout his career, Kevin was responsible for several major PBM and specialty pharmacy RFPs that drove operational improvement and substantial savings. He has significant experience in formulary development and management, rebate contracting, medical injectable fee schedule development, and overall trend management.
While at HealthNow, Kevin led the pharmacy benefit procurement on two separate occasions. This procurement effort included Commercial, Medicare and Medicaid lines of business and also included specialty pharmacy. Kevin led the transition from Accredo to Walgreens, as a component of one of the procurement efforts.
These procurement efforts resulted in tens of millions of dollars of savings for HealthNow, along with countless operation and contractual improvements.
Greg Sanderson
With over a decade in the field, Greg Sanderson is an expert in pharmacy contracting, negotiation, underwriting and data analytics. As Chief Operating Officer at AlignRx, Greg seamlessly integrates his expertise in underwriting and financial modeling. His strategic foresight and advanced analytical models have been fundamental in negotiating pharmacy deals that strike an optimal balance between cost and quality, ensuring substantial savings and superior outcomes for AlignRx's valued broker and employer group partners.
Prior to his tenure at AlignRx, Greg served as a senior financial analyst at HealthNow (now Highmark), where he was responsible for the underwriting, financial oversight and forecasting for the entire pharmacy self-insured book of business. Greg built the company’s foundational underwriting processes and financial modeling frameworks, some of which are still in use today. Setting the trajectory for projected unit cost trends and underwriting strategies, Greg enabled HealthNow to create a new profit center which became a primary source of revenue for the company. Notably, these innovations not only optimized underwriting procedures but also catalyzed transformative strategies for member retention and acquisition.
But Greg's most distinguished career milestone is playing a cornerstone role in launching AlignRx's consulting business in 2016. At AlignRx, Greg’s advanced analytic models are able to predict plan spend based upon the many variables of a PBM contract and trends such as contractual guarantees, defined terms, inflation and GDR rates. His strategy is rooted in cost reduction, spotlighting wasteful utilizations and ensuring PBMs are meeting contractual guarantees. Always client-centric, Greg's approach aids brokers and their groups in aligning with a PBM and best-in-class pharmacy programs that truly resonate with their goals.
Greg’s contributions have been instrumental in AlignRx's recognition on the Inc. 5000 List of Fastest Growing Companies. With the company achieving an average of 20% savings for its clients and boasting a commendable 98% client retention rate, it's evident that Greg plays a key role in AlignRx's commitment to its clients and the impressive 700% growth it has witnessed.
Beckie Fenrick
Beckie’s focus is helping patients, providers, health plans, employers, and PBMs realize better outcomes from their pharmacy experiences. Her track record as a pharmacy thought leader and change agent for 25 years helps her understand problems, see opportunities, and rethink better ways for AlignRx customers to handle rebates, ASO business and overall pharmacy operations.
As Chief Pharmacy Officer at AlignRx, she leverages her knowledge from advising major U.S. companies on the right ways to structure, manage, and administer their pharmacy benefits. Her experience reducing costs through innovating clinical programs, improving operational efficiency, negotiating drug rebate contracts, and automating systems to optimize productivity helps clients realize more benefit for their pharmacy spend.
Prior to joining AlignRx. Beckie was the Pharmacy Practice lead at a national Rx consulting practice. There she performed RFPs for Comcast, Pepsi, Chevron, and Sony. In addition, she was the clinical lead for BlueCross BlueShield of Florida. In both roles, she set the clinical direction for large, sophisticated entities resulting in lower costs and improved quality. At BCBS of Florida, Beckie was the clinical lead for all their procurement efforts.
Kevin Kobielski
Kevin’s experience, vision, and fundamental understanding of how the healthcare system really works helps ensure our clients get what they earn and bargain for. Kevin and his team focus on leveraging AlignRx’s expertise and empowering our clients with knowledge and strategies to select the right pharmacy and medical benefit solutions.
With unique experience as a senior executive in healthcare, Kevin knows how deals work from every angle. That vision gives his practice a fresh approach to solving the problems that hinder profitability and flexibility for TPAs, brokers, and health plans.
Before joining AlignRx, Kevin served as General Manager, Pharmacy Benefits Management (PBM) at HealthNow New York. He managed a team of clinical resources, operations personnel, and account managers responsible for over $600 million in medical and pharmacy spend, as well as 250 self-funded Rx clients covering 160,000 pharmacy lives. Throughout his career, Kevin was responsible for several major PBM and specialty pharmacy RFPs that drove operational improvement and substantial savings. He has significant experience in formulary development and management, rebate contracting, medical injectable fee schedule development, and overall trend management.
While at HealthNow, Kevin led the pharmacy benefit procurement on two separate occasions. This procurement effort included Commercial, Medicare and Medicaid lines of business and also included specialty pharmacy. Kevin led the transition from Accredo to Walgreens, as a component of one of the procurement efforts.
These procurement efforts resulted in tens of millions of dollars of savings for HealthNow, along with countless operation and contractual improvements.
Greg Sanderson
With over a decade in the field, Greg Sanderson is an expert in pharmacy contracting, negotiation, underwriting and data analytics. As Chief Operating Officer at AlignRx, Greg seamlessly integrates his expertise in underwriting and financial modeling. His strategic foresight and advanced analytical models have been fundamental in negotiating pharmacy deals that strike an optimal balance between cost and quality, ensuring substantial savings and superior outcomes for AlignRx's valued broker and employer group partners.
Prior to his tenure at AlignRx, Greg served as a senior financial analyst at HealthNow (now Highmark), where he was responsible for the underwriting, financial oversight and forecasting for the entire pharmacy self-insured book of business. Greg built the company’s foundational underwriting processes and financial modeling frameworks, some of which are still in use today. Setting the trajectory for projected unit cost trends and underwriting strategies, Greg enabled HealthNow to create a new profit center which became a primary source of revenue for the company. Notably, these innovations not only optimized underwriting procedures but also catalyzed transformative strategies for member retention and acquisition.
But Greg's most distinguished career milestone is playing a cornerstone role in launching AlignRx's consulting business in 2016. At AlignRx, Greg’s advanced analytic models are able to predict plan spend based upon the many variables of a PBM contract and trends such as contractual guarantees, defined terms, inflation and GDR rates. His strategy is rooted in cost reduction, spotlighting wasteful utilizations and ensuring PBMs are meeting contractual guarantees. Always client-centric, Greg's approach aids brokers and their groups in aligning with a PBM and best-in-class pharmacy programs that truly resonate with their goals.
Greg’s contributions have been instrumental in AlignRx's recognition on the Inc. 5000 List of Fastest Growing Companies. With the company achieving an average of 20% savings for its clients and boasting a commendable 98% client retention rate, it's evident that Greg plays a keyrole in AlignRx's commitment to its clients and the impressive 700% growth it has witnessed.
Beckie Fenrick
Beckie’s focus is helping patients, providers, health plans, employers, and PBMs realize better outcomes from their pharmacy experiences. Her track record as a pharmacy thought leader and change agent for 25 years helps her understand problems, see opportunities, and rethink better ways for AlignRx customers to handle rebates, ASO business and overall pharmacy operations.
As Chief Pharmacy Officer at AlignRx, she leverages her knowledge from advising major U.S. companies on the right ways to structure, manage, and administer their pharmacy benefits. Her experience reducing costs through innovating clinical programs, improving operational efficiency, negotiating drug rebate contracts, and automating systems to optimize productivity helps clients realize more benefit for their pharmacy spend.
Prior to joining AlignRx. Beckie was the Pharmacy Practice lead at a national Rx consulting practice. There she performed RFPs for Comcast, Pepsi, Chevron, and Sony. In addition, she was the clinical lead for BlueCross BlueShield of Florida. In both roles, she set the clinical direction for large, sophisticated entities resulting in lower costs and improved quality. At BCBS of Florida, Beckie was the clinical lead for all their procurement efforts.
